Stellar Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | $877K | Hold |
12,690
| – | – | 0.6% | 44 |
|
|
2020
Q1 | $798K | Sell |
12,690
-1,200
| -9% | -$75.5K | 0.66% | 44 |
|
|
2019
Q4 | $1.08M | Hold |
13,890
| – | – | 0.63% | 42 |
|
|
2019
Q3 | $1.02M | Sell |
13,890
-21
| -0.2% | -$1.54K | 0.66% | 43 |
|
|
2019
Q2 | $887K | Hold |
13,911
| – | – | 0.58% | 45 |
|
|
2019
Q1 | $887K | Buy |
13,911
+21
| +0.2% | +$1.34K | 0.58% | 45 |
|
|
2018
Q4 | $710K | Hold |
13,890
| – | – | 0.56% | 45 |
|
|
2018
Q3 | $806K | Hold |
13,890
| – | – | 0.52% | 48 |
|
|
2018
Q2 | $674K | Hold |
13,890
| – | – | 0.44% | 48 |
|
|
2018
Q1 | $646K | Buy |
+13,890
| New | +$646K | 0.42% | 49 |
|
|
2017
Q4 | – | Sell |
-13,890
| Closed | -$506K | – | 77 |
|
|
2017
Q3 | $506K | Hold |
13,890
| – | – | 0.36% | 56 |
|
|
2017
Q2 | $547K | Hold |
13,890
| – | – | 0.4% | 54 |
|
|
2017
Q1 | $436K | Hold |
13,890
| – | – | 0.33% | 60 |
|
|
2016
Q4 | $434K | Buy |
+13,890
| New | +$434K | 0.36% | 57 |
|
|
2016
Q2 | $422K | Hold |
12,690
| – | – | 0.46% | 49 |
|
|
2016
Q1 | $373K | Hold |
12,690
| – | – | 0.41% | 53 |
|
|
2015
Q4 | $334K | Hold |
12,690
| – | – | 0.4% | 54 |
|
|
2015
Q3 | $301K | Hold |
12,690
| – | – | 0.39% | 54 |
|
|
2015
Q2 | $301K | Sell |
12,690
-2,400
| -16% | -$56.9K | 0.33% | 55 |
|
|
2015
Q1 | $358K | Sell |
15,090
-35,340
| -70% | -$838K | 0.35% | 56 |
|
|
2014
Q4 | $1.07M | Sell |
50,430
-810
| -2% | -$17.2K | 1.15% | 39 |
|
|
2014
Q3 | $872K | Sell |
51,240
-300
| -0.6% | -$5.11K | 0.96% | 41 |
|
|
2014
Q2 | $737K | Buy |
51,540
+1,770
| +4% | +$25.3K | 0.81% | 41 |
|
|
2014
Q1 | $615K | Buy |
49,770
+1,770
| +4% | +$21.9K | 0.69% | 46 |
|
|
2013
Q4 | $526K | Buy |
+48,000
| New | +$526K | 0.56% | 52 |
|